Wed, 03/25/2009 - 17:53 — admin
GYNECARE THERMACHOICE® Uterine Balloon Therapy System Logo

You can solve heavy periods.
Treat your menorrhagia now.

Overview: GYNECARE THERMACHOICE®

If you’ve been reluctant to talk to your friends or your doctor about your heavy periods, you may not realize how common they are – or that you don’t have to accept the limits heavy periods can put on your lifestyle.

One effective treatment for heavy periods is a global endometrial ablation (GEA) procedure called GYNECARE THERMACHOICE® Uterine Balloon Therapy System. GYNECARE THERMACHOICE® is an effective, nonhormonal, permanent treatment for heavy periods. It involves a minimally invasive, 8-minute procedure that can be performed in your doctor’s office or in a hospital.

A clinical study showed:

  • 95% of women treated with GYNECARE THERMACHOICE® reported normal to no periods up to 5 years later

  • 3 out of 4 women treated had reduction of menstrual pain and cramping

  • Nearly 2 out of 3 experienced either mild or no PMS symptoms after treatment

  • 93% reported they were still satisfied with the results 5 years after treatment

You don’t have to live with heavy periods. Learn more about your period, read more about GYNECARE THERMACHOICE® or Find a doctor who can provide treatment if it’s right for you.

Next: A Solution: GYNECARE THERMACHOICE®
Print this pagePrint this page

Risk Information

GYNECARE THERMACHOICE®
GYNECARE THERMACHOICE® Uterine Balloon Therapy with Fluid Circulation

INDICATIONS: The GYNECARE THERMACHOICE® System is a thermal balloon ablation device intended to ablate the endometrial lining of the uterus in premenopausal women with menorrhagia (excessive uterine bleeding) due to benign causes for whom childbearing is complete.

CONTRAINDICATIONS: The device is contraindicated for use in a patient: with known or suspected endometrial carcinoma (uterine cancer) or premalignant change of the endometrium, such as unresolved adenomatous hyperplasia; with any anatomic or pathologic condition in which weakness of the myometrium could exist, such as history of previous classical cesarean sections or transmural myomectomy; with active genital or urinary tract infection at the time of procedure (eg, cervicitis, vaginitis, endometritis, salpingitis, or cystitis); with an intrauterine device (IUD) currently in place; or who is pregnant or who wants to become pregnant in the future.

POTENTIAL ADVERSE EFFECTS that may occur include: rupture of the uterus; thermal injury to adjacent tissue; heated liquid escaping into the vascular spaces and/or cervix, vagina, fallopian tubes, and abdominal cavity; electrical burn; hemorrhage; infection or sepsis; perforation; post-ablation tubal sterilization syndrome; complications leading to serious injury or death; complications with pregnancy (Note: pregnancy following ablation is dangerous to both the mother and the fetus); and risks associated with hysteroscopy.

WARNINGS: Failure to follow all instructions or to heed any warnings or precautions could result in serious patient injury. If a perforation is present, and the procedure is not terminated, thermal injury to adjacent tissue may occur if the heater is activated.

CAUTION: Endometrial ablation procedures using the GYNECARE THERMACHOICE® System should be performed only by medical professionals who have experience in performing procedures within the uterine cavity, such as IUD insertion or dilation and curettage (D&C), and who have adequate training and familiarity with
GYNECARE THERMACHOICE® System. Rx Only.

For more information, please consult your doctor or call 1-888-GYNECARE to speak with a nurse.

This site is published by ETHICON Women's Health & Urology, a division of ETHICON, INC., a Johnson & Johnson Company,
which is solely responsible for the content. It is intended for visitors from the US.
© ETHICON, INC. 2000-2009.

Theme